Payments to Acquire Property, Plant, and Equipment of ENANTA PHARMACEUTICALS INC from 30 Sep 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
ENANTA PHARMACEUTICALS INC quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 Sep 2011 to 31 Dec 2025.
  • ENANTA PHARMACEUTICALS INC Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Dec 2025 was $143,000, a 98% decline year-over-year.
  • ENANTA PHARMACEUTICALS INC annual Payments to Acquire Property, Plant, and Equipment for 2025 was $12,896,000, a 28% decline from 2024.
  • ENANTA PHARMACEUTICALS INC annual Payments to Acquire Property, Plant, and Equipment for 2024 was $17,948,000, a 98% increase from 2023.
  • ENANTA PHARMACEUTICALS INC annual Payments to Acquire Property, Plant, and Equipment for 2023 was $9,058,000, a 326% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $143,000 -$8,602,000 -98% 01 Oct 2025 31 Dec 2025 10-Q 11 Feb 2026 2026 Q1
Q4 2024 $8,745,000 +$7,958,000 +1011% 01 Oct 2024 31 Dec 2024 10-Q 11 Feb 2026 2026 Q1
Q4 2023 $787,000 -$2,369,000 -75% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2024 Q1
Q4 2022 $3,156,000 +$2,793,000 +769% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2024 2024 Q1
Q4 2021 $363,000 +$175,000 +93% 01 Oct 2021 31 Dec 2021 10-Q 08 Feb 2023 2023 Q1
Q4 2020 $188,000 -$300,000 -61% 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022 2022 Q1
Q4 2019 $488,000 +$104,000 +27% 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021 2021 Q1
Q4 2018 $384,000 -$120,000 -24% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q1
Q4 2017 $504,000 -$449,000 -47% 01 Oct 2017 31 Dec 2017 10-Q 08 Feb 2019 2019 Q1
Q4 2016 $953,000 -$1,244,000 -57% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018 2018 Q1
Q4 2015 $2,197,000 +$1,941,000 +758% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017 2017 Q1
Q4 2014 $256,000 +$232,000 +967% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q1
Q4 2013 $24,000 +$13,000 +118% 01 Oct 2013 31 Dec 2013 10-Q 06 Feb 2015 2015 Q1
Q4 2012 $11,000 01 Oct 2012 31 Dec 2012 10-Q 13 Feb 2014 2014 Q1

ENANTA PHARMACEUTICALS INC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,896,000 -$5,052,000 -28% 01 Oct 2024 30 Sep 2025 10-K 19 Nov 2025 2025 FY
2024 $17,948,000 +$8,890,000 +98% 01 Oct 2023 30 Sep 2024 10-K 19 Nov 2025 2025 FY
2023 $9,058,000 +$6,933,000 +326% 01 Oct 2022 30 Sep 2023 10-K 19 Nov 2025 2025 FY
2022 $2,125,000 +$1,375,000 +183% 01 Oct 2021 30 Sep 2022 10-K 27 Nov 2024 2024 FY
2021 $750,000 -$695,000 -48% 01 Oct 2020 30 Sep 2021 10-K 22 Nov 2023 2023 FY
2020 $1,445,000 -$3,972,000 -73% 01 Oct 2019 30 Sep 2020 10-K 23 Nov 2022 2022 FY
2019 $5,417,000 +$2,436,000 +82% 01 Oct 2018 30 Sep 2019 10-K 24 Nov 2021 2021 FY
2018 $2,981,000 +$475,000 +19% 01 Oct 2017 30 Sep 2018 10-K 25 Nov 2020 2020 FY
2017 $2,506,000 -$2,232,000 -47% 01 Oct 2016 30 Sep 2017 10-K 27 Nov 2019 2019 FY
2016 $4,738,000 +$2,402,000 +103% 01 Oct 2015 30 Sep 2016 10-K 29 Nov 2018 2018 FY
2015 $2,336,000 +$1,308,000 +127% 01 Oct 2014 30 Sep 2015 10-K 11 Dec 2017 2017 FY
2014 $1,028,000 +$422,000 +70% 01 Oct 2013 30 Sep 2014 10-K 09 Dec 2016 2016 FY
2013 $606,000 +$354,000 +140% 01 Oct 2012 30 Sep 2013 10-K 11 Dec 2015 2015 FY
2012 $252,000 -$193,000 -43% 01 Oct 2011 30 Sep 2012 10-K 11 Dec 2014 2014 FY
2011 $445,000 01 Oct 2010 30 Sep 2011 10-K 18 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.